Literature DB >> 17957139

SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways.

Simon J Allison1, Jo Milner.   

Abstract

SIRT3, one of seven mammalian sirtuins, is a NAD-dependent deacetylase. SIRT3 localizes to mitochondria where it deacetylates and thus activates acetyl-CoA synthetase 2 (AceCS2), indicating a role for SIRT3 in metabolism. Here we provide evidence that SIRT3 also impacts upon apoptosis and cell growth control. Using RNAi under basal (non-stress) conditions we show that SIRT3 is required for apoptosis induced by selective silencing of Bcl-2 in HCT116 human epithelial cancer cells. Identical treatment of ARPE19 epithelial non-cancer cells induces G(1) growth arrest which also proved to be SIRT3-dependent. Previously we have identified SIRT1 and JNK2 as constitutive suppressors of apoptosis in HCT116 cells. We now demonstrate that SIRT3 functions in JNK2-regulated apoptosis but is dispensable for SIRT1-regulated apoptosis. SIRT3 is also dispensable for stress-induced apoptosis. Thus the pro-apoptotic functioning of SIRT3 is selectively coupled with defined pathways regulating cell survival under basal conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957139     DOI: 10.4161/cc.6.21.4866

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  78 in total

Review 1.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

Review 2.  Mitochondrial SIRT3 and heart disease.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Valluvan Jeevanandam; Mahesh P Gupta
Journal:  Cardiovasc Res       Date:  2010-08-04       Impact factor: 10.787

3.  Sirtuin-3 (SIRT3) and the Hallmarks of Cancer.

Authors:  Turki Y Alhazzazi; Pachiyappan Kamarajan; Eric Verdin; Yvonne L Kapila
Journal:  Genes Cancer       Date:  2013-03

4.  Key regulators of mitochondrial biogenesis are increased in kidneys of growth hormone receptor knockout (GHRKO) mice.

Authors:  Adam Gesing; Andrzej Bartke; Feiya Wang; Malgorzata Karbownik-Lewinska; Michal M Masternak
Journal:  Cell Biochem Funct       Date:  2011-07-14       Impact factor: 3.685

5.  Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3.

Authors:  Lei Jin; Heidi Galonek; Kristine Israelian; Wendy Choy; Michael Morrison; Yu Xia; Xiaohong Wang; Yihua Xu; Yuecheng Yang; Jesse J Smith; Ethan Hoffmann; David P Carney; Robert B Perni; Michael R Jirousek; Jean E Bemis; Jill C Milne; David A Sinclair; Christoph H Westphal
Journal:  Protein Sci       Date:  2009-03       Impact factor: 6.725

6.  Mitochondrial sirtuins as therapeutic targets for age-related disorders.

Authors:  Jennifer Shih; Gizem Donmez
Journal:  Genes Cancer       Date:  2013-03

7.  The Poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes.

Authors:  Ben Buelow; Yumei Song; Andrew M Scharenberg
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

8.  Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity.

Authors:  Songtao Li; Xiaobing Dou; Hua Ning; Qing Song; Wei Wei; Ximei Zhang; Chen Shen; Jiaxin Li; Changhao Sun; Zhenyuan Song
Journal:  Hepatology       Date:  2017-07-20       Impact factor: 17.425

9.  Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.

Authors:  C-L Song; H Tang; L-K Ran; B C B Ko; Z-Z Zhang; X Chen; J-H Ren; N-N Tao; W-Y Li; A-L Huang; J Chen
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Sirtuin deacetylases: a new target for melanoma management.

Authors:  Melissa J Wilking; Chandra K Singh; Minakshi Nihal; Mary A Ndiaye; Nihal Ahmad
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.